Author

Rhian Jacob 1

1 Roche Products Limited,Welwyn Garden City,United Kingdom

ETROLIZUMAB AS INDUCTION THERAPY IN MODERATE TO SEVERE CROHN’S DISEASE: RESULTS FROM BERGAMOT COHORT 1

William Sandborn, Julian Panés, Jennifer Jones, Azra Hassanali, Rhian Jacob, Zaineb Sharafali, Young S. Oh, Swati Tole

ETROLIZUMAB TREATMENT MODULATES MADCAM-1 LEVELS IN SERUM IN PATIENTS WITH CROHN'S DISEASE

William Sandborn, Julian Panés, Franklin Fuh, Rich Erickson, Rhian Jacob, Wenhui Zhang, Meina Tang, Jacqueline McBride

Responder Definitions for the Crohn's Disease Patient-Reported Outcomes Signs and Symptoms (CD-PRO/SS) Tool Using Patients with Crohn's Disease Treated with Etrolizumab

Peter D. R. Higgins, Kendra DeBusk, Rhian Jacob, Azra Hassanali, Zaineb Sharafali, Young S. Oh, Alison Matsui

Item 1 - 3 / 3
1